Joseph Lobacki
Direktor/Vorstandsmitglied bei SUTRO BIOPHARMA, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Joseph Lobacki
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SUTRO BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 01.02.2017 | - |
| Independent Dir/Board Member | 01.02.2017 | - |
Karriereverlauf von Joseph Lobacki
Ehemalige bekannte Positionen von Joseph Lobacki
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 13.05.2020 | 04.01.2024 |
| Vorstandsvorsitzender | 13.05.2020 | 04.01.2024 | |
| Präsident | 13.05.2020 | 04.01.2024 | |
| VERASTEM, INC. | Corporate Officer/Principal | 04.01.2018 | 01.01.2019 |
Finch Research & Development LLC
 Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Geschäftsführer | 01.11.2016 | 01.12.2017 |
| FINCH THERAPEUTICS GROUP, INC. | Geschäftsführer | 01.11.2013 | 01.12.2017 |
| MEDIVATION INC | Corporate Officer/Principal | 08.12.2014 | 01.10.2016 |
| CELATOR PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 19.12.2013 | 12.07.2016 |
| Independent Dir/Board Member | 19.12.2013 | 12.07.2016 | |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01.01.2012 | 01.12.2014 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 06.12.2011 | 01.04.2014 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
Ausbildung von Joseph Lobacki
| Boston College | Undergraduate Degree |
| Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 16 |
Operativ
| Corporate Officer/Principal | 6 |
| Director/Board Member | 3 |
| Chief Operating Officer | 3 |
Sektoral
| Health Technology | 12 |
| Consumer Services | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Private Unternehmen | 10 |
|---|---|
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Celator Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. The company was founded by Lawrence David Mayer, and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| SangStat Medical Corp. | Health Technology |
Cell Pathways, Inc.
 Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Cell Pathways, Inc. develops and commercializes drugs for the prevention and treatment of cancer | Health Technology |
Finch Research & Development LLC
Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Health Technology |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Health Technology |
| Micromet Inc. |
- Börse
- Insiders
- Joseph Lobacki
- Erfahrung
